Cargando…

Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia

INTRODUCTION: Diagnosing ventilator-associated pneumonia (VAP) remains challenging. Soluble urokinase plasminogen activator receptor (suPAR) has prognostic value in critically ill patients with systemic infection. We hypothesised that plasma suPAR levels accurately predict development of VAP. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Oort, Pouline M., Bos, Lieuwe D., Póvoa, Pedro, Ramirez, Paula, Torres, Antoni, Artigas, Antonio, Schultz, Marcus J., Martin-Loeches, Ignacio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431752/ https://www.ncbi.nlm.nih.gov/pubmed/30918897 http://dx.doi.org/10.1183/23120541.00212-2018

Ejemplares similares

Tumor necrosis factor receptor 1 (TNFRI) for ventilator-associated pneumonia diagnosis by cytokine multiplex analysis
por: Martin-Loeches, Ignacio, et al.
Publicado: (2015)

Composition and diversity analysis of the lung microbiome in patients with suspected ventilator-associated pneumonia
por: Fenn, Dominic, et al.
Publicado: (2022)

Exhaled Breath Metabolomics for the Diagnosis of Pneumonia in Intubated and Mechanically-Ventilated Intensive Care Unit (ICU)-Patients
por: van Oort, Pouline M. P., et al.
Publicado: (2017)

BreathDx – molecular analysis of exhaled breath as a diagnostic test for ventilator–associated pneumonia: protocol for a European multicentre observational study
por: van Oort, Pouline M. P., et al.
Publicado: (2017)

Evaluation of the Kinetics of Pancreatic Stone Protein as a Predictor of Ventilator-Associated Pneumonia
por: Ceccato, Adrian, et al.
Publicado: (2023)

Untargeted Molecular Analysis of Exhaled Breath as a Diagnostic Test for Ventilator-Associated Lower Respiratory Tract Infections (BreathDx)
por: van Oort, Pouline MP, et al.
Publicado: (2022)

Ventilator associated tracheobronchitis and pneumonia: one infection with two faces
por: Martin-Loeches, Ignacio, et al.
Publicado: (2023)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study
por: Póvoa, Pedro, et al.
Publicado: (2016)

Respiratory research networks in Europe and beyond: aims, achievements and aspirations for the 21st century
por: Martin-Loeches, Ignacio, et al.
Publicado: (2017)

Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort study
por: Backes, Yara, et al.
Publicado: (2011)

Invasive Pulmonary Aspergillosis in Ventilator-associated Pneumonia: The Hidden Enemy?
por: Torres, Antoni, et al.
Publicado: (2020)

Endothelial dysfunction triggers acute respiratory distress syndrome in patients with sepsis: a narrative review
por: Cusack, Rachael, et al.
Publicado: (2023)

Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants
por: Haastrup, Eva, et al.
Publicado: (2014)

Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
por: Godtfredsen, Nina S., et al.
Publicado: (2018)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

Soluble urokinase plasminogen activator receptor level in individuals of advanced age
por: Wlazel, Rafal N., et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
por: Luo, Shengyuan, et al.
Publicado: (2022)

Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Level as a Predictor of the Severity of Community-Acquired Pneumonia
por: Tsai, Ping-Kun, et al.
Publicado: (2019)

Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
por: Cyrille, Nicole B., et al.
Publicado: (2016)

Plasma Soluble Urokinase Plasminogen Activator Receptor in Children with Urinary Tract Infection
por: Wittenhagen, Per, et al.
Publicado: (2011)

A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
por: Spinale, Joann M., et al.
Publicado: (2014)

The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
por: Erkut, Nergiz, et al.
Publicado: (2016)

Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients
por: Wlazeł, Rafał Nikodem, et al.
Publicado: (2018)

Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD
por: Böcskei, Renáta M., et al.
Publicado: (2019)

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea
por: Bocskei, Renata Marietta, et al.
Publicado: (2020)

Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
por: Velissaris, Dimitrios, et al.
Publicado: (2022)

Accuracy of the clinical pulmonary infection score to differentiate ventilator-associated tracheobronchitis from ventilator-associated pneumonia
por: Gaudet, Alexandre, et al.
Publicado: (2020)

Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography
por: Sommerer, Claudia, et al.
Publicado: (2019)

A week seems to be weak: tailoring duration of antibiotic treatment in Gram-negative ventilator-associated pneumonia
por: Martin-Loeches, Ignacio, et al.
Publicado: (2013)

Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
por: Vallecoccia, Maria Sole, et al.
Publicado: (2020)

ARDS: challenges in patient care and frontiers in research
por: Bos, Lieuwe D., et al.
Publicado: (2018)

Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation
por: Ichihara, Noboru, et al.
Publicado: (2017)

Serum soluble urokinase plasminogen activator receptor in adolescents: interaction of chronic pain and obesity
por: Raff, Hershel, et al.
Publicado: (2020)

Clinical value of soluble urokinase type plasminogen activator receptors in chronic kidney disease
por: Ahmed, Reem M., et al.
Publicado: (2019)

Soluble Urokinase Plasminogen Activator Receptor as a Diagnostic and Prognostic Biomarker in Cardiac Disease
por: Velissaris, Dimitrios, et al.
Publicado: (2021)

Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects
por: El‑Patal, Mohamed Abd‑Ellatif, et al.
Publicado: (2022)

Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis
por: Hindy, George, et al.
Publicado: (2022)

Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
por: Rovina, Nikoletta, et al.
Publicado: (2020)

A way towards ventilator-associated lower respiratory tract infection research
por: Martin-Loeches, Ignacio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_70eviub9kkq461pvor3ip1kr15